Gee, now doesn't this make make it much easier for big pharma, when asked about the results of a study that didn't flatter their concoction, to say, "What study??"
But I suppose it also protects the university when patients who are injured by undocumented adverse events, or are simply not cured by worthless therapies, have no researchers to point the finger at.
C. Hathaway
"This, shipmates, this is that other lesson; and woe to that pilot of the living God who slights it. Woe to him whom this world charms from Gospel duty! Woe to him who seeks to pour oil upon the waters when God has brewed them into a gale! Woe to him who seeks to please rather than to appal! Woe to him whose good name is more to him than goodness! Woe to him who, in this world, courts not dishonor! Woe to him who would not be true, even though to be false were salvation! Yea, woe to him who as the great Pilot Paul has it, while preaching to others is himself a castaway!"
----Father Mapple, Moby Dick, Chapter 9
At 10:57 AM 6/16/03 -0400, you wrote:
>Our Clinical Trials Office reports that 4 out of 5 pharma clinical trial sponsors are now insisting that the institution keep confidential the fact that we are conducting a particular clinical trial.
>
>In essence, they are saying that we cannot publish reports to the Board of Trustees and the State which contains the specifics of a clinical trial, e.g., study drug, indication, etc. In fact, they are insisting that our internal databases not contain this information.
>
>Is this a problem anyone else has encountered?
>
>Leonard P. Paplauskas
>Associate Vice President for Research Administration
>University of Connecticut Health Center
>MC1920
>Farmington, CT 06030-1920
>xxxxxx@adp.uchc.edu (external e-mail)
>xxxxxx@exchange.uchc.edu (internal e-mail)
>860-679-3173 (phone)
>860-679-1371 (fax)
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================